AHPA Rewrites NDI Guidance, Argues FDA Proposes Premarket Approval For Supplements
By
Carolyn B. Phenicie / Email the Author / “The Tan Sheet” Dec. 12, 2011, Vol. 19, No. 50
Dietary Supplements / Word Count: 802 / Article # 05111212012
Executive Summary
The NDI draft guidance “seeks to erect extra-legal barriers to market entry” and change supplement regulation “from the notification process described under law to an FDA approval process,” AHPA argues, joining other trade groups urging FDA to withdraw the guidance
Already a Subscriber?
Log in for complete access.
Log In
Questions?
Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.